{"id":1385,"date":"2007-04-01T12:06:00","date_gmt":"2007-04-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2007\/leserbrief-13"},"modified":"2007-04-01T12:06:00","modified_gmt":"2007-04-01T10:06:00","slug":"leserbrief-13","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2007\/leserbrief-13","title":{"rendered":"Leserbrief"},"content":{"rendered":"<p>Wu Wei Zi: Unseri\u00f6se Versprechungen Fragen von Dr. R.B. aus Berlin: >> Patienten machen mich darauf aufmerksam, dass Leinersan\u2019s Wu Wei Zi Schisandra N (Wirkstoff: Schisandra chinensis D3, Hom\u00f6opathisches Arzneimittel) offenbar von Diamant Natuur B.V., Landgraaf, Niederlande hergestellt und angeboten wird. In der Anzeige wird angegeben, dass &#8222;chinesische Wissenschaftler&#8220; berichtet h\u00e4tten, die Beere k\u00f6nne &#8222;die [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wu Wei Zi: Unseri\u00f6se Versprechungen Fragen von Dr. R.B. aus Berlin: >> Patienten machen mich darauf aufmerksam, dass Leinersan\u2019s Wu Wei Zi Schisandra N (Wirkstoff: Schisandra chinensis D3, Hom\u00f6opathisches Arzneimittel) offenbar von Diamant Natuur B.V., Landgraaf, Niederlande hergestellt und angeboten wird. In der Anzeige wird angegeben, dass &#8222;chinesische Wissenschaftler&#8220; berichtet h\u00e4tten, die Beere k\u00f6nne &#8222;die [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3317,3318],"class_list":["post-1385","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-schisandra-chinensis","tag-wu-wei-zi"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1385"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1385\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}